Weight Related
Conditions
Medical weight care, not a diet.

A clinical approach to weight-related health conditions addressing the metabolic, hormonal, and lifestyle factors driving weight and its impact on your overall health, with physician-supervised treatment including GLP-1 therapy.

Book an Appointment
Florida Insurances
Georgia Insurances
New York Insurances
South Carolina Insurances
North Carolina Insurances
Weight Is a Medical Issue Weight Management From a Clinical Lens

Weight-related conditions are among the most undertreated areas in primary care, often dismissed as lifestyle failures rather than recognized as complex medical conditions with physiological drivers including insulin resistance, hormonal dysregulation, and sleep dysfunction. At Superior Health Medical & Wellness, Dr. Akers treats weight as the medical issue it is, with the same clinical rigor she applies to any other chronic condition.

Whether you are managing obesity, struggling with weight gain related to a thyroid condition or medication, working to reduce cardiovascular risk through weight loss, or seeking evidence-based medical weight loss with GLP-1 therapy, Dr. Akers builds a care plan that addresses the full picture.

Book a Weight Management Consultation
Weight Related Conditions at Superior Health
Weight Related Conditions What We Address

Weight-related health management at Superior Health is comprehensive and individualized. Dr. Akers evaluates the medical contributors to weight, addresses the health conditions driven by excess weight, and builds a treatment plan calibrated to your specific situation.

Obesity is a chronic, complex metabolic condition driven by genetics, hormonal signaling, neurological factors, and environmental influences. Dr. Akers evaluates the metabolic underpinnings of your weight, reviews contributing medications, assesses cardiovascular risk, and builds a comprehensive management plan combining dietary guidance, physical activity, behavioral support, and medication when appropriate, including GLP-1 therapies such as Ozempic, Wegovy, Zepbound, Mounjaro, and Foundayo.
GLP-1 receptor agonists including semaglutide and tirzepatide have transformed medically supervised weight loss by reducing appetite, improving insulin sensitivity, and producing significant sustained weight reduction. Dr. Akers evaluates candidacy, prescribes in-office, manages titration and side effects, and monitors metabolic response to optimize outcomes.
Metabolic syndrome is the cluster of abdominal obesity, elevated blood pressure, high blood sugar, high triglycerides, and low HDL that dramatically increases cardiovascular and diabetes risk. Dr. Akers identifies metabolic syndrome, addresses each component systematically, and tracks improvement as weight and metabolic markers improve.
Insulin resistance drives weight gain and elevated blood sugar and often precedes type 2 diabetes by years. Dr. Akers identifies insulin resistance through appropriate testing and addresses it through targeted dietary changes, metformin when appropriate, and weight management strategies that specifically improve insulin sensitivity.
Excess weight significantly elevates blood pressure, LDL cholesterol, and inflammatory markers. Dr. Akers manages cardiovascular risk reduction and weight simultaneously, recognizing that weight loss produces improvements across multiple risk factors at once.
Hypothyroidism, PCOS, testosterone deficiency in men, and other hormonal imbalances contribute significantly to weight gain and make standard weight loss interventions less effective. Dr. Akers screens for and addresses hormonal contributors as part of every comprehensive weight evaluation.
Many commonly prescribed medications cause significant weight gain. Dr. Akers reviews all medications for weight effects and substitutes weight-neutral or weight-reducing alternatives when clinically appropriate.
Obstructive sleep apnea and poor sleep quality drive weight gain through hormonal mechanisms. Dr. Akers addresses sleep health as a clinical component of weight management rather than treating it as a separate issue.
NAFLD affects approximately 25 percent of adults in the US, is strongly associated with obesity and insulin resistance, and can progress to cirrhosis without treatment. Dr. Akers screens for NAFLD in at-risk patients and manages it through targeted weight loss and metabolic optimization.
Long-term weight maintenance requires sustained medical support. Dr. Akers provides ongoing monitoring of weight, labs, and comorbidities, adjusting the plan as weight loss plateaus or metabolic adaptation occurs rather than treating weight loss as a one-time event.
Why It Matters Why Weight Deserves Medical Treatment
Dr. Akers providing preventive care
01 Weight Is Physiological, Not Moral

Body weight is regulated by complex physiological systems that actively resist weight loss. The medical evidence is clear that obesity is a chronic disease. Dr. Akers approaches weight management with clinical objectivity, targeting the physiological drivers rather than simply advising less eating and more exercise.

02 Comorbidities Respond to Weight Loss

Even modest weight loss of 5 to 10 percent of body weight produces clinically meaningful improvements in blood pressure, blood sugar, triglycerides, sleep apnea, and joint pain. These improvements reduce medication burden and cardiovascular risk simultaneously.

03 GLP-1 Therapy Changed the Standard of Care

Semaglutide and tirzepatide produce average weight losses of 15 to 20 percent of body weight in clinical trials. Dr. Akers evaluates candidacy and manages these medications as part of comprehensive weight care.

Pap smear and cervical health screening
Understanding Weight Science Why Weight Is Not Just About Willpower

Energy balance is regulated by a sophisticated neuroendocrine system that actively defends a set point weight. When weight is lost through restriction, the body responds by lowering metabolic rate and increasing hunger, creating physiological pressure to regain.

GLP-1 medications work partly by overriding this compensatory hunger response. Dr. Akers uses this understanding of weight physiology to select the right combination of interventions for your specific metabolic profile.

Vaccines and immunizations at Superior Health Medical
Treatment Approach Building a Weight Management Plan That Works

Effective weight management combines dietary modification, physical activity, behavioral strategies, treatment of contributing medical conditions, and medication when appropriate. Dr. Akers evaluates which components are most relevant and builds a layered plan.

Follow-up is essential. Weight responds to changes in sleep, stress, medications, and hormones, and the management plan needs to adapt accordingly. Dr. Akers provides ongoing monitoring and adjusts the plan at each visit based on your current response.

Book Your Weight Management Visit
Frequently Asked Questions Weight Related Conditions
Questions Answered
Yes. Obesity is recognized as a chronic disease by the American Medical Association. It is driven by complex physiological, genetic, hormonal, and environmental factors. Treating it as a medical condition rather than a lifestyle choice changes the clinical approach and produces better outcomes.
GLP-1 receptor agonists including semaglutide and tirzepatide work by mimicking a gut hormone that signals fullness, slows gastric emptying, and improves insulin sensitivity. They produce average weight losses of 15 to 20 percent of body weight in clinical trials with additional cardiovascular benefits.
GLP-1 therapy is indicated for patients with a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions. Dr. Akers evaluates your full medical history to determine candidacy.
The most common side effects are gastrointestinal, including nausea and diarrhea, particularly during dose titration. These typically improve over time. Dr. Akers titrates doses slowly to minimize side effects and monitors for any concerning developments.
Metabolic syndrome is the cluster of abdominal obesity, elevated blood pressure, high triglycerides, low HDL, and elevated blood sugar that collectively indicate significantly elevated cardiovascular and diabetes risk.
Yes, many commonly prescribed medications cause significant weight gain. Dr. Akers reviews all medications for weight effects and substitutes weight-neutral alternatives when medically appropriate.
Sleep deprivation increases the hunger hormone ghrelin and decreases the satiety hormone leptin, producing increased hunger. Obstructive sleep apnea creates a difficult cycle where weight gain worsens sleep apnea, which further impairs weight management.
The best dietary approach is the one you can sustain. Dr. Akers helps identify which approach fits your metabolic profile, preferences, and health conditions rather than prescribing a generic protocol.
GLP-1 medications prescribed for diabetes are covered by most plans. Coverage for weight loss without a diabetes diagnosis varies by plan and often requires prior authorization. Dr. Akers office handles prior authorizations.
Most patients see meaningful weight loss within the first month of GLP-1 therapy, with maximum effect typically seen at 12 to 18 months. Dr. Akers sets realistic expectations and monitors progress at each visit.
Bariatric surgery produces the largest and most sustained weight loss but carries operative risks. GLP-1 medications now produce results approaching surgical outcomes for many patients. Dr. Akers discusses both approaches and provides surgical referrals when appropriate.
Long-term weight maintenance requires sustained behavioral changes and often ongoing medical management. GLP-1 medications typically require continued use to maintain weight loss. Dr. Akers provides ongoing follow-up and support.